Peng Wei, Wang Zhuo, Fan Hong
Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, No. 42 Baiziting Road, Nanjing, 210009, China.
Laboratory of Cancer Research, Jiangsu Cancer Hospital, Nanjing Medical University, No. 42 Baiziting Road, Nanjing, 210009, China.
Pathol Oncol Res. 2017 Jul;23(3):651-656. doi: 10.1007/s12253-016-0172-4. Epub 2016 Dec 24.
Long noncoding RNA (lncRNA) have been reported to modulate oncogenesis and be used to be target for tumor. The role of lncRNA NEAT1 (nuclear paraspeckle assembly transcript 1, Gene ID: 283131) in colorectal cancer (CRC) keeps unknown. This work was to investigate the pattern of lncRNA NEAT1 (NEAT1) expression in CRC and its functional value and biological significance. NEAT1 expression was analyzed in 56 cancer tissues and cell lines in CRC cases. Results showed that NEAT1 was significantly overexpressed in CRC cells and tissues. Clinicpathologic detection verified that high NEAT1 expression associated with bulk in CRC. The serum contents of NEAT1 were observably elevated comparing with healthy cases (P < 0.05). The levels of NEAT1 were elevated in distinguishing CRC from normal (ROC = 0.9471; P < 0.01). Moreover, Kaplan-Meier analysis found that NEAT1 elevation led to adverse survival (P < 0.05). Further experiments illustrated that of NEAT1 knockdown signally inhibited growth and facilitated apoptosis. Importantly, we confirmed that Akt signaling pathway was inactivated after loss of NEAT1 in CRC. Taken together, this work support the first evidence that NEAT1 can be used to be a promising biomarker and target for novel treatment for human CRC.
据报道,长链非编码RNA(lncRNA)可调节肿瘤发生,并有望成为肿瘤治疗靶点。lncRNA NEAT1(核旁斑组装转录本1,基因ID:283131)在结直肠癌(CRC)中的作用尚不清楚。本研究旨在探讨lncRNA NEAT1(NEAT1)在CRC中的表达模式及其功能价值和生物学意义。分析了56例CRC病例的癌组织和细胞系中NEAT1的表达情况。结果显示,NEAT1在CRC细胞和组织中显著高表达。临床病理检测证实,CRC中NEAT1高表达与肿瘤大小相关。与健康对照相比,CRC患者血清中NEAT1含量明显升高(P<0.05)。NEAT1水平在区分CRC与正常组织方面升高(ROC=0.9471;P<0.01)。此外,Kaplan-Meier分析发现,NEAT1升高导致患者预后不良(P<0.05)。进一步实验表明,敲低NEAT1可显著抑制CRC细胞生长并促进其凋亡。重要的是,我们证实CRC中NEAT1缺失后Akt信号通路失活。综上所述,本研究首次证明NEAT1有望成为人类CRC的生物标志物和新型治疗靶点。